COVID-19 Health Center Survey Testing Dashboard
Visit a dashboard on COVID-19 testing broken down by race/ethnicity.
COVID-19 Health Center Survey Maps
View maps of the COVID-19 survey data, including testing capacity, temporary site closures, and staff ability to work.
National Summary Report
Latest data from October 16, 2020
The Health Resources and Services Administration uses the information collected to: help track health center capacity and the impact of COVID-19 on health center operations, patients, and staff; and better understand training and technical assistance, funding, and other health center resource needs.
Health Center COVID-19 Survey Tool Questions
Health Center COVID-19 Survey Tool User Guide
View Health Center Program Look-Alike Survey Data for COVID-19
Number of Health Center respondents =979 (71% of all Health Centers)
Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patient Testing
| Metrics | Value |
|---|---|
| Health Centers with COVID-19 Testing Capacity, Virus Detection (PCR, antigen) | 96.73% |
| Health Centers with COVID-19 Drive-Up/Walk Up Testing Capacity, Virus Detection (PCR, antigen)1 | 80.57% |
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)1
| Metrics | Value |
|---|---|
| Less Than 1 Hour | 6.55% |
| 12 Hours or Less | 2.32% |
| 24 Hours | 11.30% |
| 2-3 Days | 64.31% |
| 4-5 Days | 13.52% |
| More Than 5 Days | 2.01% |
Number of Patients Tested
| Metrics | Value |
|---|---|
| Patients Tested for COVID-19, Any Test Type2,3 | 188,106 |
| Racial and/or Ethnic Minority Patients Tested for COVID-19, Any Test Type3 | 44.32% |
| Patients Tested Positive for COVID-19, Any Test Type2,3 | 19,174 |
| Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Any Test Type3 | 50.88% |
| Patients Tested for COVID-19, Virus Detection (PCR, antigen)2 | 179,561 |
| Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) | 43.74% |
| Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)2 | 17,424 |
| Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) | 51.58% |
| Patients Tested for COVID-19, Antibody Detection (serology)2 | 8,545 |
| Racial and/or Ethnic Minority Patients Tested for COVID-19, Antibody Detection (serology) | 56.44% |
| Patients Tested Positive for COVID-19, Antibody Detection (serology)2 | 1,750 |
| Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Antibody Detection (serology) | 43.94% |
Patients by Race and Ethnicity
| Race/Ethnicity | Patients Tested, Virus Detection (PCR, antigen)4 | Patients Tested Positive, Virus Detection (PCR, antigen)4 | Patients Tested, Antibody Detection (serology)4 | Patients Tested Positive, Antibody Detection (serology)4 |
|---|---|---|---|---|
| White, Non-Hispanic/Latino Patients | 36.88% | 32.61% | 21.49% | 26.34% |
| White, Hispanic/Latino Patients | 16.95% | 24.86% | 25.20% | 15.43% |
| Black/African American, Non-Hispanic/Latino Patients | 12.54% | 8.41% | 10.22% | 11.14% |
| Black/African American, Hispanic/Latino Patients | 1.00% | 1.48% | 1.17% | 1.20% |
| Asian Patients5 | 2.44% | 2.71% | 3.58% | 1.83% |
| American Indian/Alaska Native Patients5 | 1.74% | 0.87% | 0.43% | 0.23% |
| Native Hawaiian/Other Pacific Islander Patients5 | 0.81% | 1.26% | 0.41% | 0.34% |
| Patients with More than one race5 | 2.07% | 2.72% | 5.48% | 3.60% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 6.18% | 9.27% | 9.96% | 10.17% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 3.02% | 3.28% | 1.98% | 1.94% |
| Unreported/Refused to Report Race and Ethnicity | 16.36% | 12.53% | 20.09% | 27.77% |
Operations and Staff
| Metrics | Value |
|---|---|
| Health Center Weekly Visits Compared to Pre-COVID 19 Weekly Visits | 82.55% |
| Health Center Sites Temporarily Closed | 585 |
| Staff Tested Positive for COVID-19, Virus Detection (PCR, antigen) | 682 |
| Health Center Staff Unable to Work (due to site/service closure, exposure, family/home obligations, lack of PPE, etc.) | 4.12% |
| Average Percent of Health Center Visits Conducted Virtually | 26.66% |
Health Centers with an adequate supply of Personal Protective Equipment (PPE):
| Type of PPE | 6 or Fewer Days | 7-13 Days | 14-20 Days | 21-27 Days | 28 or More Days | No Supply Challenge at this time |
|---|---|---|---|---|---|---|
| Surgical Masks | 1.23% | 4.09% | 11.95% | 7.87% | 37.18% | 37.69% |
| N95/PPR Masks | 2.96% | 5.92% | 12.05% | 10.11% | 37.90% | 31.05% |
| Gowns | 1.23% | 4.90% | 11.75% | 9.50% | 35.85% | 36.77% |
| Gloves | 2.04% | 6.44% | 10.83% | 9.81% | 35.04% | 35.85% |
| Face Masks/Goggles | 1.33% | 3.88% | 10.11% | 8.99% | 34.83% | 40.86% |
Results from States and Territories
Select a state or use the dropdown menu to see each state or territory's summary report.
- Alabama
- Alaska
- American Samoa
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- District of Columbia
- Federated States of Micronesia
- Florida
- Georgia
- Guam
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Marshall Islands
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Northern Mariana Islands
- Ohio
- Oklahoma
- Oregon
- Palau
- Pennsylvania
- Puerto Rico
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Virgin Islands
- Washington
- West Virginia
- Wisconsin
- Wyoming
1 Only health centers that responded having COVID-19 testing capacity are included, n=947.
2 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
3 “Any test type” includes virus detection and antibody detection testing numbers. Care should be taken when drawing conclusions from combined testing numbers or in racial/ethnic minority percentages. Comparison of data in later weeks or in racial and/or ethnic minorities is subject to interpretation as the nature and purpose of antibody detection tests evolve over time.
4 Percentages may not add to 100% due to rounding to the hundredths.
5 Includes Hispanic/Latino and Non-Hispanic/Latino.



